The investigations carried out by Schlee Villodre 9 on TMAs from 216 breast cancer patients (97 cases of TNBC) after neoadjuvant therapy showed different H-score median as cutoff value (160) to discriminate between high and low NDRG1 expression. The gene discussed is NDRG1; the disease is breast carcinoma.